Australian Government Seeking 71% Hike In Device Application Fees
This article was originally published in The Gray Sheet
Executive Summary
Australia's Therapeutic Goods Administration is likely to recognize lower-risk (Class I and IIa) device approvals granted by European Notified Bodies, under legislation expected by September 2000.
You may also be interested in...
Proposed Australian Device Approval System Has Web-Based Application
Legislation that would authorize a new regulatory system for medical devices will be reintroduced into the Australian Parliament as early as March
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”